EnGene Encouraged By Promising Response Rates In Bladder Cancer Trial
enGene Holdings Inc. (NASDAQ:ENGN) stock is edging higher on Tuesday, with a session volume of 18.62 million compared to an average volume of 266.85 thousand, as per data from Benzinga Pro.
Benzinga ·
Benzinga
